These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18371145)

  • 21. Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease.
    Tran A; Benzaken S; Saint-Paul MC; Guzman-Granier E; Hastier P; Pradier C; Barjoan EM; Demuth N; Longo F; Rampal P
    Eur J Gastroenterol Hepatol; 2000 Sep; 12(9):989-93. PubMed ID: 11007134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis.
    Guéchot J; Laudat A; Loria A; Serfaty L; Poupon R; Giboudeau J
    Clin Chem; 1996 Apr; 42(4):558-63. PubMed ID: 8605673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
    Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between Serum Hyaluronic Acid with Steatosis, Non alcoholic Steato-hepatitis and Fibrosis in Patients with Chronic Hepatitis C Virus Infection.
    Mahmoud HS; Ghweil AAS; Osman GS; Ezz-Eldin S Bazeed S; Helal MM
    Trop Gastroenterol; 2016; 37(2):93-100. PubMed ID: 30234278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of serum procollagen C-proteinase enhancer 1 level as a fibrosis marker in patients with chronic hepatitis B.
    Gokce O; Ozenirler S; Atak Yucel A; Oruklu N; Yilmaz Esendagli G; Karahan S
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):918-924. PubMed ID: 29683980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
    Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
    J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection.
    Wong VS; Hughes V; Trull A; Wight DG; Petrik J; Alexander GJ
    J Viral Hepat; 1998 May; 5(3):187-92. PubMed ID: 9658372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection.
    Berres ML; Papen S; Pauels K; Schmitz P; Zaldivar MM; Hellerbrand C; Mueller T; Berg T; Weiskirchen R; Trautwein C; Wasmuth HE
    J Hepatol; 2009 Feb; 50(2):370-6. PubMed ID: 19070929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive accuracy of serum hyaluronic acid as a non-invasive marker of fibrosis in a cohort of multi-transfused Egyptian children with β-thalassaemia major.
    El-Shabrawi MH; Zein El Abedin MY; Omar N; Kamal NM; Elmakarem SA; Khattab S; El-Sayed HM; El-Hennawy A; Ali AS
    Arab J Gastroenterol; 2012 Jun; 13(2):45-8. PubMed ID: 22980590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum hyaluronic acid as a predictor of fibrosis in chronic hepatitis B and C virus infection.
    Nath NC; Rahman MA; Khan MR; Hasan MS; Bhuiyan TM; Hoque MN; Kabir MM; Raha AK; Jahan B
    Mymensingh Med J; 2011 Oct; 20(4):614-9. PubMed ID: 22081179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum YKL-40 is increased in patients with hepatic fibrosis.
    Johansen JS; Christoffersen P; Møller S; Price PA; Henriksen JH; Garbarsch C; Bendtsen F
    J Hepatol; 2000 Jun; 32(6):911-20. PubMed ID: 10898311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.
    Parés A; Deulofeu R; Giménez A; Caballería L; Bruguera M; Caballería J; Ballesta AM; Rodés J
    Hepatology; 1996 Dec; 24(6):1399-403. PubMed ID: 8938169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum hyaluronic acid as a marker of hepatic fibrosis.
    Khan JA; Khan FA; Dilawar M; Ijaz A; Khan NA; Mehmood T
    J Coll Physicians Surg Pak; 2007 Jun; 17(6):323-6. PubMed ID: 17623578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease.
    Hartley JL; Brown RM; Tybulewicz A; Hayes P; Wilson DC; Gillett P; McKiernan P
    J Pediatr Gastroenterol Nutr; 2006 Aug; 43(2):217-21. PubMed ID: 16877988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnostic value of five serum markers for liver fibrosis].
    Luo R; Yang S; Xie J; Zhao Z; He Y; Yao J
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of serum biomarkers in predicting fibrosis progression in pediatric and adult hepatitis C virus chronic infection.
    Valva P; Casciato P; Diaz Carrasco JM; Gadano A; Galdame O; Galoppo MC; Mullen E; De Matteo E; Preciado MV
    PLoS One; 2011; 6(8):e23218. PubMed ID: 21858035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
    Trocme C; Leroy V; Sturm N; Hilleret MN; Bottari S; Morel F; Zarski JP
    J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced liver fibrosis panel as a predictor of liver fibrosis in chronic hepatitis C patients.
    Fernandes FF; Ferraz ML; Andrade LE; Dellavance A; Terra C; Pereira G; Pereira JL; Campos F; Figueiredo F; Perez RM
    J Clin Gastroenterol; 2015 Mar; 49(3):235-41. PubMed ID: 24714186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease.
    El-Gindy I; El Rahman AT; El-Alim MA; Zaki SS
    Egypt J Immunol; 2003; 10(1):27-35. PubMed ID: 15719620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients.
    Stibbe KJ; Verveer C; Francke J; Hansen BE; Zondervan PE; Kuipers EJ; de Knegt RJ; van Vuuren AJ
    Scand J Gastroenterol; 2011 Jul; 46(7-8):962-72. PubMed ID: 21623677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.